CLVS has been beat up for a loooong time. On a 3 hr chart it appears that we are seeing a bottoming inver H&S formation. Company also is making positive news about Rubraca that just met the primary endpoint of significantly improving Progression-Free Survival vs. Chemotherapy. Completely a momentum based trade with a tight stop loss. PS Never ever take any of...
Disclaimer, this is only for entertainment and education purposes and doesn't serve by any means as a buy or sell recommendation. Personally I hold both long term long positions and occasionally short term short position, for disclosure purpose.
Posted an earlier idea about CLVS weeks ago. However the wall street shorted this one like crazy so that they can accumulate, most likely, like they always do, as BldSuckers. Looks like some news will come out soon.. Disclaimer, this is only for entertainment and education purposes and doesn't serve by any means as a buy or sell recommendation. Personally I...
CLOVIS maker of FDA approved Rubraca® which is a treatment of ovarian cancer, fallopian tube cancer, or primary peritoneal cancer whose cancer has come back and who are in response (complete or partial response) to a platinum-based chemotherapy. www.rubraca.com Sitting at a pretty interesting area right now, sure it will get some more movement soon as we are...
the stock is still very volatile with a beta of about 1.4. Let's see if it can break the upper trend line first. Disclaimer, this is only for entertainment and education purposes and doesn't serve by any means as a buy or sell recommendation.
I published an idea about CLVS early on but since then the stock took a hit and I incurred some loss from the trade. However, by looking at the volume and OBV lately, you can tell that people are buying the stock in expectation for something big. Disclaimer, this is only for entertainment and education purposes and doesn't serve by any means as a buy or sell...
finance.yahoo.com Disclaimer, this is only for entertainment purpose and doesn't serve by any means as a buy or sell recommendation.
Hello! Friends, This would be a great short Opportunity, IF NASDAQ:CLVS breaks down the support line at $6.64 !!
Crossed over MACD. Looks like it will cross over upper Bollinger Band. Looking to sell in $10-$11 range.
CLVS - Like this over 7.81. Target 1 11.43, Target 2 14.83. Stop signal 6.43 - However would update this as new support reveals itself closer to the entry signal.
CLVS - Like this over 7.81. Target 1 11.43, Target 2 14.83. Stop signal 6.43 - However would update this as new support reveals itself closer to the entry signal.
the beta is high with this one
Take profit 1: 7.50 Take profit 2: 10.00 FDA decision on the companies product Twirla. Womans contraceptive patch BRUDAC ADcomm voted 14-1 in favor. 200mmil marketcap with a 4bill addressable market. Chasing approval since 2013. Approval IS NOT for certain. They could be issued a CRL. Could go much higher on approval. Manage your risk accordingly.
We have a triple rejection of the sub 8.60 price range on the weekly candles, setup doesn't get much better than that. Consolidation has taken longer than expected but what else is new haha.
I would be cautious of the handle getting any longer. Other than that it looks to be at the end of consolidation.